Toth Financial Advisory’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-75
| Closed | -$1.21K | – | 771 |
|
|
2023
Q3 | $1.21K | Hold |
75
| – | – | ﹤0.01% | 695 |
|
|
2023
Q2 | $3.11K | Hold |
75
| – | – | ﹤0.01% | 593 |
|
|
2023
Q1 | $4.51K | Hold |
75
| – | – | ﹤0.01% | 548 |
|
|
2022
Q4 | $5.5K | Hold |
75
| – | – | ﹤0.01% | 492 |
|
|
2022
Q3 | $6K | Hold |
75
| – | – | ﹤0.01% | 526 |
|
|
2022
Q2 | $5K | Hold |
75
| – | – | ﹤0.01% | 509 |
|
|
2022
Q1 | $6K | Hold |
75
| – | – | ﹤0.01% | 517 |
|
|
2021
Q4 | $6K | Hold |
75
| – | – | ﹤0.01% | 539 |
|
|
2021
Q3 | $9K | Hold |
75
| – | – | ﹤0.01% | 497 |
|
|
2021
Q2 | $17K | Hold |
75
| – | – | ﹤0.01% | 399 |
|
|
2021
Q1 | $10K | Hold |
75
| – | – | ﹤0.01% | 460 |
|
|
2020
Q4 | $13K | Buy |
75
+45
| +150% | +$7.8K | ﹤0.01% | 380 |
|
|
2020
Q3 | $3K | Buy |
+30
| New | +$3K | ﹤0.01% | 450 |
|